Isoniazid Syrup Suppliers & Bulk Manufacturers
Available Forms: Oral Syrup
Available Strengths: 50 mg
Reference Brands: Generic formulations marketed under different names
Category:
Respiratory Disorder
Isoniazid is used to treat tuberculosis (TB) or prevent its return (reactivation). It may be given alone, or in combination with other medicines, to treat TB or to prevent its return (reactivation).
Isoniazid Syrup is available in Oral Syrup
and strengths such as 50 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Isoniazid Syrup is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Isoniazid Syrup can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Isoniazid (INH) is a first-line antitubercular antibiotic widely used for the treatment of active Mycobacterium tuberculosis (TB) infections. It has been a cornerstone of TB therapy for decades due to its potent bactericidal activity and well-established efficacy. Isoniazid functions as a prodrug that is activated by the bacterial enzyme catalase-peroxidase (KatG). Upon activation, it generates reactive radicals and adducts that specifically inhibit the synthesis of mycolic acids, which are essential components of the mycobacterial cell wall. This disruption compromises the structural integrity of the bacterium, leading to cell death.
INH is often used in combination with other antituberculosis agents to enhance therapeutic effectiveness and prevent the development of drug resistance. Its synergistic action with other medications in standard TB regimens makes it an indispensable component of multidrug therapy. Available in oral tablet and syrup formulations, INH allows for precise dosing across different patient populations, including children and adults who require flexible administration options. With a strong safety profile and proven clinical outcomes, Isoniazid remains a critical choice for healthcare professionals in the global fight against tuberculosis.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing